These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28294596)

  • 1. The Macrolide Toxin Mycolactone Promotes Bim-Dependent Apoptosis in Buruli Ulcer through Inhibition of mTOR.
    Bieri R; Scherr N; Ruf MT; Dangy JP; Gersbach P; Gehringer M; Altmann KH; Pluschke G
    ACS Chem Biol; 2017 May; 12(5):1297-1307. PubMed ID: 28294596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced Synthesis of Mycolactone Restores the Pathogenesis of
    Strong E; Hart B; Wang J; Orozco MG; Lee S
    Front Immunol; 2022; 13():750643. PubMed ID: 35401531
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer.
    En J; Kitamoto S; Kawashima A; Yonezawa S; Kishi Y; Ishii N; Goto M
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005834. PubMed ID: 28783752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry of mycolactones, the causative toxins of Buruli ulcer.
    Kishi Y
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6703-8. PubMed ID: 21383136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sec61 blockade by mycolactone: A central mechanism in Buruli ulcer disease.
    Demangel C; High S
    Biol Cell; 2018 Nov; 110(11):237-248. PubMed ID: 30055020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.
    Sarfo FS; Phillips R; Wansbrough-Jones M; Simmonds RE
    Cell Microbiol; 2016 Jan; 18(1):17-29. PubMed ID: 26572803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium ulcerans mycolactone interferes with adhesion, migration and proliferation of primary human keratinocytes and HaCaT cell line.
    Graziola F; Colombo E; Tiberio R; Leigheb G; Bozzo C
    Arch Dermatol Res; 2017 Apr; 309(3):179-189. PubMed ID: 28229230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
    Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
    PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in human
    Fevereiro J; Fraga AG; Capela C; Sopoh GE; Dossou A; Ayelo GA; Peixoto MJ; Cunha C; Carvalho A; Rodrigues F; Pedrosa J
    Emerg Microbes Infect; 2021 Dec; 10(1):223-225. PubMed ID: 33467983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.
    Hall BS; Hsieh LT; Sacre S; Simmonds RE
    Front Immunol; 2021; 12():788146. PubMed ID: 35154073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
    Tobias NJ; Seemann T; Pidot SJ; Porter JL; Marsollier L; Marion E; Letournel F; Zakir T; Azuolas J; Wallace JR; Hong H; Davies JK; Howden BP; Johnson PD; Jenkin GA; Stinear TP
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e553. PubMed ID: 19936295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology.
    Foulon M; Robbe-Saule M; Manry J; Esnault L; Boucaud Y; Alcaïs A; Malloci M; Fanton d'Andon M; Beauvais T; Labarriere N; Jeannin P; Abel L; Saint-André JP; Croué A; Delneste Y; Boneca IG; Marsollier L; Marion E
    PLoS Pathog; 2020 Dec; 16(12):e1009107. PubMed ID: 33338061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview: Mycolactone , the Macrolide Toxin of Mycobacterium ulcerans.
    Röltgen K; Pluschke G
    Methods Mol Biol; 2022; 2387():105-108. PubMed ID: 34643906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
    Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
    Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer.
    Hall B; Simmonds R
    Biochem Soc Trans; 2014 Feb; 42(1):177-83. PubMed ID: 24450648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.
    Bolz M; Ruggli N; Borel N; Pluschke G; Ruf MT
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004678. PubMed ID: 27128097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
    Fraga AG; Martins TG; Torrado E; Huygen K; Portaels F; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions.
    Hsieh LT; Dos Santos SJ; Hall BS; Ogbechi J; Loglo AD; Salguero FJ; Ruf MT; Pluschke G; Simmonds RE
    PLoS Pathog; 2022 Jan; 18(1):e1010280. PubMed ID: 35100311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buruli ulcer and mycolactone-producing mycobacteria.
    Nakanaga K; Yotsu RR; Hoshino Y; Suzuki K; Makino M; Ishii N
    Jpn J Infect Dis; 2013; 66(2):83-8. PubMed ID: 23514902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
    Walsh DS; Portaels F; Meyers WM
    Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.